Zilver PTX Post-market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 2-Year Results
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-086X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Zilver PTX Post-market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 2-Year Results ; day:8 ; month:11 ; year:2018 ; pages:1-7
CardioVascular and interventional radiology ; (8.11.2018), 1-7
- Urheber
-
Kichikawa, Kimihiko
Ichihashi, Shigeo
Yokoi, Hiroyoshi
Ohki, Takao
Nakamura, Masato
Komori, Kimihiro
Nanto, Shinsuke
O’Leary, Erin E.
Lottes, Aaron E.
Snyder, Scott A.
Dake, Michael D.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00270-018-2110-1
- URN
-
urn:nbn:de:101:1-2018122702203947174624
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kichikawa, Kimihiko
- Ichihashi, Shigeo
- Yokoi, Hiroyoshi
- Ohki, Takao
- Nakamura, Masato
- Komori, Kimihiro
- Nanto, Shinsuke
- O’Leary, Erin E.
- Lottes, Aaron E.
- Snyder, Scott A.
- Dake, Michael D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
One-Year Outcomes of the Paclitaxel-Eluting Stent for TASC C and D Femoropopliteal Lesions in Real World
Bare metal stent versus paclitaxel eluting stent for intermediate length femoropopliteal arterial lesions (BATTLE trial): study protocol for a randomized controlled trial
Twelve-month results from the MAJESTIC trial of the Eluvia paclitaxel-eluting stent for treatment of obstructive femoropopliteal disease
Two-Year Follow-up of Sirolimus-Eluting Stents versus Paclitaxel-Eluting Stents in Acute Myocardial Infarction
Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the zilver PTX randomized trial
Drug-Eluting Coronary Stents: Hypersensitivity Reactions to Paclitaxel - A Case Report
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion
Treatment of Femoropopliteal Arterial Disease in Critical Limb Ischemia with Drug Eluting Stents: A Real World Experience
Untersuchungen zur Anwendbarkeit von Polyelektrolytmultischichten für drug eluting stents zur lokalen Freisetzung von Paclitaxel
Mortality risk of femoropopliteal paclitaxel-coated devices remains inconclusive
A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
One-Year Outcomes of the Paclitaxel-Eluting Stent for TASC C and D Femoropopliteal Lesions in Real World
Bare metal stent versus paclitaxel eluting stent for intermediate length femoropopliteal arterial lesions (BATTLE trial): study protocol for a randomized controlled trial
Twelve-month results from the MAJESTIC trial of the Eluvia paclitaxel-eluting stent for treatment of obstructive femoropopliteal disease
Two-Year Follow-up of Sirolimus-Eluting Stents versus Paclitaxel-Eluting Stents in Acute Myocardial Infarction
Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the zilver PTX randomized trial
Drug-Eluting Coronary Stents: Hypersensitivity Reactions to Paclitaxel - A Case Report
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion
Treatment of Femoropopliteal Arterial Disease in Critical Limb Ischemia with Drug Eluting Stents: A Real World Experience
Untersuchungen zur Anwendbarkeit von Polyelektrolytmultischichten für drug eluting stents zur lokalen Freisetzung von Paclitaxel
Mortality risk of femoropopliteal paclitaxel-coated devices remains inconclusive
A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
One-Year Outcomes of the Paclitaxel-Eluting Stent for TASC C and D Femoropopliteal Lesions in Real World
Bare metal stent versus paclitaxel eluting stent for intermediate length femoropopliteal arterial lesions (BATTLE trial): study protocol for a randomized controlled trial
Twelve-month results from the MAJESTIC trial of the Eluvia paclitaxel-eluting stent for treatment of obstructive femoropopliteal disease
Two-Year Follow-up of Sirolimus-Eluting Stents versus Paclitaxel-Eluting Stents in Acute Myocardial Infarction
Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the zilver PTX randomized trial
Drug-Eluting Coronary Stents: Hypersensitivity Reactions to Paclitaxel - A Case Report
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion
Treatment of Femoropopliteal Arterial Disease in Critical Limb Ischemia with Drug Eluting Stents: A Real World Experience
Untersuchungen zur Anwendbarkeit von Polyelektrolytmultischichten für drug eluting stents zur lokalen Freisetzung von Paclitaxel